Geneos Wealth Management Inc. Omeros Corp Transaction History

Geneos Wealth Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 08, 2021	SELL	$14.81 - $19.13 $9,478 - $12,243	-640 Reduced 19.2%	2,693 $40,000
Q4 2020 May 19, 2021	BUY	$10.14 - $15.19 $6,489 - $9,721	640 Added 23.77%	3,333 $60,000
Q4 2018 Sep 07, 2021	BUY	$10.72 - $16.73 $7,428 - $11,593	693 Added 34.65%	2,693 $31,000
Q1 2016 Sep 07, 2021	BUY	N/A	2,000	2,000 $31,000

139

25.9M

718K

598K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $576M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.